Physician profile
Matthew S Baker
NPI 1285894774
$2,058.52
in general payments reported to CMS, 2019-2025
14 companies · $704 in 2025
The $704 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $554 · 2020: $149 · 2021: $118 · 2022: $205 · 2023: $96.57 · 2024: $233 · 2025: $704.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,033.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,032.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cordis US Corp. | $497.30 | 2025 | Mynx Control Venous |
| Biosense Webster, INC. | $344.92 | 2021-2025 | Carto 3 |
| Biotronik INC. | $258.12 | 2019-2022 | |
| Medtronic Vascular, INC. | $213.28 | 2019-2020 | |
| Neotract INC. | $198.87 | 2019 | |
| Abbott Laboratories | $149.25 | 2019-2025 | Ensite, Viewmate, Ensite Precision |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $112.50 | 2020 | |
| Medtronic, INC. | $97.42 | 2021-2025 | Sphere-9, Linq II |
| Boston Scientific Corporation | $85.95 | 2019-2025 | Farapulse |
| Rochester Medical Corporation | $33.97 | 2022 | |
| Janssen Pharmaceuticals, INC | $19.52 | 2023 | Xarelto |
| C. R. Bard, INC. & Subsidiaries | $16.41 | 2023 | Bard Urinary Drainage Bag |
| Mission Pharmacal Company | $15.81 | 2024 | Uribel Tabs |
| Cardiva Medical, INC. | $15.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.